Home
Help
Coronavirus (COVID-19) Alerts and Registration
Alert Compliance Data
Login
Javascript is disabled because of the browser settings on this machine. So, a few features might not be available.
-
Search Alert Broadcasts (publicly issued alerts)
Reference:
Keyword:
Issue date:
From:
To:
Originator: (For multiple select: Ctrl key + Click)
CAS - Helpdesk - Team
CAS Helpdesk Team
CAS Helpdesk Team/Emergency
CAS-Helpdesk Team
CMO Messaging
Department of Health
DH Estates and Facilities
DH Estates and Facilities/National Patient Safety Agency
DH Supply Disruption
DHSC & NHS England and Improvement: Supply disruption alert
DHSC Supply Disruption Alert
Medical Devices Safety Bulletin
MHRA Dear Doctor Letter
MHRA Drug Alerts
MHRA Medical Device Alerts
National Institute for Health and Clinical Excellence/National Patient Safety Agency
National Patient Safety Agency
National Patient Safety Alert - MHRA
National Patient Safety Alert - NHS England & NHS Improvement
NHS Blood and Transplant
NHS Digital
NHS England
NHS England and NHS Improvement Estates and Facilities
NHS England Operations and Information Directorate – National Primary Care Commissioning Team
NHS Estates
NHS Improvement
NHS Improvement Estates and Facilities
NHS Improvement Estates and Facilities
Others
Testing-08-April
Reference
Alert Title
Originated By
Issue Date
Status
SDA/2021/001
Methylprednisolone powder for solution for injection (all strengths) - Supply disruption
DHSC & NHS England and Improvement: Supply disruption alert
14-Jan-2021
Issued
CEM/CMO/2021/002
Supporting doctors throughout the COVID-19 pandemic
CMO Messaging
12-Jan-2021
Issued
CEM/CMO/2021/001
COVID-19 Therapeutic Alert: Interleukin-6 inhibitors (tocilizumab or sarilumab) for patients admitte ...
CMO Messaging
08-Jan-2021
Issued
SDA/2020/012(U2)
Lithium carbonate (Priadel) 200mg and 400mg tablets - Supply Disruption Update
DHSC & NHS England and Improvement: Supply disruption alert
04-Jan-2021
Issued
CEM/CMO/2020/044
Letter from the UK Chief Medical Officers regarding the UK COVID-19 vaccination programmes
CMO Messaging
31-Dec-2020
Issued
EL (20)A/61
CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, MEDAC GMBH (T/A MEDAC PHARMA LLP), SODIOFOLIN 50MG/ML SO ...
MHRA Drug Alerts
29-Dec-2020
Issued
CEM/CMO/2020/043
Immediate Actions in response to SARS-CoV-2 virus new variants of concerns
CMO Messaging
24-Dec-2020
Issued
CEM/CMO/2020/042
Therapeutic Anticoagulation (Heparin) in the Management of Severe COVID-19 (SARS-CoV-2 Positive) Pat ...
CMO Messaging
23-Dec-2020
Issued
CEM/CMO/2020/041
Indemnity arrangements for the Covid-19 vaccination programme
CMO Messaging
23-Dec-2020
Issued
EL (20)A/60
CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, MERCK SHARP & DOHME LIMITED, ZERBAXA 1G/0.5G POWDER ...
MHRA Drug Alerts
16-Dec-2020
Issued
1
2
3
4
5
6
7
8
9
10
...
* Alerts highlighted in blue are National Patient Safety Alerts. Further information about this type of alert
can be found in this update.
Contact our helpdesk
Email:
safetyalerts@mhra.gov.uk